Article Information
History
- April 18, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 18, 2020 - 16:39).
- Version 2 (April 18, 2020 - 22:57).
- Version 3 (April 19, 2020 - 22:36).
- Version 4 (April 30, 2020 - 19:30).
- Version 5 (July 8, 2020 - 11:30).
- View Version 6, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Collin D. Heera,b,
- Daniel J. Sandersonc,&,
- Yousef M.O. Alhammadd,&,
- Mark S. Schmidtb,&,
- Samuel A.J. Trammellb,*,
- Stanley Perlmane,
- Michael S. Cohenc,
- Anthony R. Fehrd,# and
- Charles Brennerb,#
- aFree Radical and Radiation Biology Program, University of Iowa, United States
- bDepartment of Biochemistry, University of Iowa, United States
- cDepartment of Chemical Physiology & Biochemistry, Oregon Health Sciences University, United States
- dDepartment of Molecular Biosciences, University of Kansas, United States
- eDepartment of Microbiology & Immunology, University of Iowa, United States
- ↵#correspondence to arfehr{at}ku.edu and charles-brenner{at}uiowa.edu
↵& equal contributions
Posted April 18, 2020.
Coronavirus Infection and PARP Expression Dysregulate the NAD Metabolome: A Potentially Actionable Component of Innate Immunity
